Pages that link to "Q28364912"
Jump to navigation
Jump to search
The following pages link to Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel (Q28364912):
Displaying 50 items.
- Alternative splicing in the C-terminus of CaV2.2 controls expression and gating of N-type calcium channels (Q24680174) (← links)
- The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential (Q26781422) (← links)
- Ionotropic glutamate receptors and voltage-gated Ca²⁺ channels in long-term potentiation of spinal dorsal horn synapses and pain hypersensitivity (Q26823531) (← links)
- Food-Derived Natural Compounds for Pain Relief in Neuropathic Pain (Q28068743) (← links)
- Pain perception in mice lacking the beta3 subunit of voltage-activated calcium channels (Q28216827) (← links)
- CACNA1B mutation is linked to unique myoclonus-dystonia syndrome (Q28249383) (← links)
- The alpha2delta auxiliary subunit reduces affinity of omega-conotoxins for recombinant N-type (Cav2.2) calcium channels (Q28263842) (← links)
- Characterization of acute somatosensory pain transmission in P/Q-type Ca(2+) channel mutant mice, leaner (Q28508612) (← links)
- Effects of ablation of N- and R-type Ca(2+) channels on pain transmission (Q28586209) (← links)
- N-type calcium channel alpha1B subunit (Cav2.2) knock-out mice display hyperactivity and vigilance state differences (Q28588723) (← links)
- Role of voltage-gated calcium channels in ascending pain pathways (Q30436560) (← links)
- Targeting chronic and neuropathic pain: the N-type calcium channel comes of age. (Q30501239) (← links)
- Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs (Q33271332) (← links)
- Upregulation of casein kinase 1epsilon in dorsal root ganglia and spinal cord after mouse spinal nerve injury contributes to neuropathic pain (Q33583147) (← links)
- Contribution of primary afferent channels to neuropathic pain (Q33810382) (← links)
- N-type calcium current, Cav2.2, is enhanced in small-diameter sensory neurons isolated from Nf1+/- mice (Q33822127) (← links)
- Activation of MrgC receptor inhibits N-type calcium channels in small-diameter primary sensory neurons in mice (Q33923266) (← links)
- An approach to identify microRNAs involved in neuropathic pain following a peripheral nerve injury (Q34107081) (← links)
- N-type calcium channel in the pathogenesis of experimental autoimmune encephalomyelitis (Q34236583) (← links)
- A PEPTIDE UNCOUPLING CRMP-2 FROM THE PRESYNAPTIC Ca(2+) CHANNEL COMPLEX DEMONSTRATES EFFICACY IN ANIMAL MODELS OF MIGRAINE AND AIDS THERAPY-INDUCED NEUROPATHY. (Q34291550) (← links)
- Molecular pharmacology of high voltage-activated calcium channels (Q34303106) (← links)
- Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin (Q34579804) (← links)
- Arthritis and pain. Future targets to control osteoarthritis pain (Q34636446) (← links)
- Descending control of pain (Q34659433) (← links)
- Molecular mechanisms of analgesia induced by opioids and ethanol: is the GIRK channel one of the keys? (Q34922365) (← links)
- Insights from mouse models of absence epilepsy into Ca2+ channel physiology and disease etiology (Q34937491) (← links)
- Mechanistic Stratification of Antineuralgic Agents (Q35106968) (← links)
- Attenuation of inflammatory and neuropathic pain behaviors in mice through activation of free fatty acid receptor GPR40. (Q35117995) (← links)
- Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex (Q35561043) (← links)
- In vivo analysis of voltage-dependent calcium channels (Q35682326) (← links)
- Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel–CRMP-2 signaling complex (Q35693714) (← links)
- Up-regulation of Cavβ3 subunit in primary sensory neurons increases voltage-activated Ca2+ channel activity and nociceptive input in neuropathic pain (Q35774149) (← links)
- Domain III regulates N-type (CaV2.2) calcium channel closing kinetics (Q35902607) (← links)
- The therapeutic potential of Na+ and Ca2+ channel blockers in pain management (Q35906952) (← links)
- Neuronal calcium channels: splicing for optimal performance (Q36026611) (← links)
- Role of decreased sensory neuron membrane calcium currents in the genesis of neuropathic pain. (Q36148010) (← links)
- New targets for neuropathic pain therapeutics (Q36219689) (← links)
- Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides (Q36318896) (← links)
- Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation (Q36381994) (← links)
- Targeting N-type and T-type calcium channels for the treatment of pain (Q36437519) (← links)
- Voltage-gated calcium channels and idiopathic generalized epilepsies. (Q36525559) (← links)
- Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide (Q36644488) (← links)
- Venom peptides as a rich source of cav2.2 channel blockers (Q36807192) (← links)
- Voltage-gated calcium channels in chronic pain: emerging role of alternative splicing (Q37128809) (← links)
- α2δ-1 gene deletion affects somatosensory neuron function and delays mechanical hypersensitivity in response to peripheral nerve damage (Q37231466) (← links)
- Acute inhibition of Ca2+/calmodulin-dependent protein kinase II reverses experimental neuropathic pain in mice (Q37268022) (← links)
- Phorbol ester modulation of Ca2+ channels mediates nociceptive transmission in dorsal horn neurones (Q37277479) (← links)
- Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides (Q37360619) (← links)
- Pharmacological Inhibition of Voltage-gated Ca(2+) Channels for Chronic Pain Relief (Q37362037) (← links)
- Pregabalin in the treatment of chronic pain: an overview (Q37401263) (← links)